The Valley Desk

NCT01578707 · Interventional trial

A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

Overall registry status Completed

Phase 3

Conditions Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov